Peptide | IC50 | tR | Hydropathicity (GRAVY) |
---|---|---|---|
μM | min | ||
PMBN | 2.5 | 21.3 | −1.589 |
[Phe6]PMBN | 5 | 21.3 | −1.700 |
[Ala6]PMBN | 12 | 15.7 | −1.811 |
[d-Trp5]PMBN | 4 | 21.7 | −2.000 |
[d-Tyr5]PMBN | 25 | 16.4 | −2.044 |
Displacement of LPS-bound dansyl-PMBN by PMBN analogs. Increasing concentrations of PMBN peptides were added to E. coli- LPS solution (3 μg/ml) bound to dansyl-PMBN (0.55 μM). The fluorescence inhibition was measured 5 min after each addition at excitation and emission wavelengths of 340 and 485 nm, respectively. Data represent the mean derived from four experiments. Analytical HPLC was preformed on VydacTM RP-18 column using a linear gradient of t = 0 min, B = 0%; t = 55 min, B = 80%. Grand average of hydropathicity (GRAVY) was calculated using the Web-available program developed by Kyte and Doolittle (http://www.expasy.ch/cgi-bin/protscale.pl).